TOPIC: 2022 American Transplant Congress

Evaluating the Risk and Benefit of Once Daily Delayed Release Mycophenolate in Pediatric Kidney Transplant Recipients
L. Maestretti¹, A. McGrath¹, A. Fong¹, A. Brubaker², A. Gallo³, P. Grimm³, A. Chaudhuri³
Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients
M. Borsh¹, M. Leick¹, A. Donovan², C. McAdam-Marx², M. Keck¹
Evaluation of Compliance and Efficacy with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Tacrolimus in Kidney Transplant Recipients
M. Nikirk¹, J. Chen¹, E. Tillman²
Evaluation of Conversion from Immediate Release (IR) Tacrolimus to LCP-Tacrolimus (Envarsus XR®, LCP) in Heart Transplant Recipients
E. Foster¹, A. Iaria¹, J. Negrelli², M. Fine², M. Yu², M. Liebo²
Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients
R. Gordon¹, K. Dewey¹, R. Jariwala¹, B. Yen¹, J. Kukreja², S. Hays², J. Singer², R. Florez¹
Evaluation of Diabetes-Free Life Expectancy Among Living Kidney Donors and Non-Donors with Obesity: A Longitudinal Cohort Study
C. Killian¹, R. Reed¹, M. McLeod¹, P. MacLennan¹, V. Kumar¹, S. Brooks¹, A. Maynor¹, L. Stanford¹, G. Baker¹, C. Schinstock², J. Silkensen³, G. Roll⁴, D. Segev⁵, B. Orandi¹, C. Lewis¹, J. Locke¹
Evaluation of Different Initial Tacrolimus Dosing Regimens in Pediatric Post-Liver Transplantation
A. F. Alghanem¹, A. Alsmari¹, H. Joharji²
Evaluation of Donor Exclusion Criteria in Living Donor Liver Transplantation: A Single-Center Experience
D. Daskalaki, M. E. Akoad, J. Kim, C. J. Simon, Y. Cheah
Evaluation of Genotype Based Clustering Method of Single-Cell RNA-Sequencing Data from Human Kidney Allograft Biopsies
G. Thareja¹, A. Belkadi¹, S. Rahim², H. Yang², F. B. Mueller², K. Suhre¹, M. Suthanthiran², T. Muthukumar²
Evaluation of GLP-1 Receptor Agonist Use in the Solid Organ Transplant Population
S. E. Lawrence, M. R. Norvell, K. Schwarz, B. Crowther, P. Klem